BioGeneration Ventures
also invests · investor profileNaarden, NL · 5 known investors
Find your way into BioGeneration Ventures
BioGeneration Ventures (BGV) is the early-stage arm of the Forbion-BGV platform of funds, investing in and supporting biotech and life sciences companies across their stages of development. It partners with academic institutions, healthcare and pharma companies, and other venture investors across the Netherlands, EU and US.
Investors · 5
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BAug 2026 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease - BioSpacebiospace.com · Aug 2026Frequently asked questions
- What does BioGeneration Ventures do?
- BioGeneration Ventures (BGV) is the early-stage arm of the Forbion-BGV platform of funds, investing in and supporting biotech and life sciences companies across their stages of development. It partners with academic institutions, healthcare and pharma companies, and other venture investors across the Netherlands, EU and US.
- Who are BioGeneration Ventures's investors?
- BioGeneration Ventures's investors include BOM, KfW Capital, Novo Holdings, European Investment Fund, KfW.
- Where is BioGeneration Ventures headquartered?
- BioGeneration Ventures is headquartered in Naarden, NL.